Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations

Marlies J Valstar1, Aida M Bertoli-Avella, Marja W Wessels

  • 1Department of Clinical Genetics, Erasmus University Medical Center, Dr. Molewaterplein 50, Rotterdam, The Netherlands.

Human Mutation
|March 17, 2010
PubMed

Insights

Mucopolysaccharidosis III D (MPS IIID) is a rare genetic disorder. Researchers identified 15 new mutations in the GNS gene, expanding understanding of this lysosomal storage disease.

Area of Science:

  • Genetics
  • Biochemistry
  • Rare Diseases

Background:

  • Mucopolysaccharidosis III D (MPS IIID), also known as Sanfilippo disease type D, is a rare autosomal recessive lysosomal storage disorder.
  • It results from a deficiency in N-acetylglucosamine-6-sulphate sulphatase (GNS), an enzyme crucial for heparan sulphate degradation.
  • Previously, only 20 patients and seven GNS gene mutations were documented.

Purpose of the Study:

  • To investigate the clinical phenotype of new MPS IIID patients.
  • To identify novel mutations in the GNS gene in a cohort of patients with suspected MPS IIID.
  • To characterize the spectrum of genetic alterations in the GNS gene associated with MPS IIID.

Main Methods:

  • Clinical data from 12 new MPS IIID patients from 10 families were collected and analyzed.
  • Mutation analysis of the GNS gene was performed in 16 patients, including 14 index cases.
  • Sequence analysis of the coding regions of the GNS gene was employed to identify mutations.

Main Results:

  • The clinical presentation of the studied MPS IIID patients aligns with previously described cases, characterized by normal early development followed by behavioral issues, developmental stagnation, and progressive decline in communication and motor skills.
  • Sequence analysis identified 15 novel mutations in the GNS gene, including 3 missense, 1 nonsense, 4 splice site, 3 frameshift, 3 large deletions, and 1 in-frame small deletion.
  • These findings include the first reported missense mutations and a significant proportion of large rearrangements in the GNS gene.

Conclusions:

  • The study expands the mutational landscape of MPS IIID by identifying numerous novel GNS gene mutations.
  • The findings highlight the importance of including quantitative techniques for detecting large rearrangements in routine GNS gene mutation screening for MPS IIID.
  • This research contributes to a better understanding of the genetic basis and clinical spectrum of MPS IIID, aiding in diagnosis and potential therapeutic strategies.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...